1. Home
  2. SONN vs BACK Comparison

SONN vs BACK Comparison

Compare SONN & BACK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SONN
  • BACK
  • Stock Information
  • Founded
  • SONN N/A
  • BACK 2000
  • Country
  • SONN United States
  • BACK United States
  • Employees
  • SONN N/A
  • BACK N/A
  • Industry
  • SONN Biotechnology: Pharmaceutical Preparations
  • BACK Medical Specialities
  • Sector
  • SONN Health Care
  • BACK Health Care
  • Exchange
  • SONN Nasdaq
  • BACK Nasdaq
  • Market Cap
  • SONN 2.5M
  • BACK 2.2M
  • IPO Year
  • SONN N/A
  • BACK 2019
  • Fundamental
  • Price
  • SONN $1.51
  • BACK $1.30
  • Analyst Decision
  • SONN Strong Buy
  • BACK
  • Analyst Count
  • SONN 2
  • BACK 0
  • Target Price
  • SONN $38.00
  • BACK N/A
  • AVG Volume (30 Days)
  • SONN 2.8M
  • BACK 38.5K
  • Earning Date
  • SONN 12-17-2024
  • BACK 12-18-2024
  • Dividend Yield
  • SONN N/A
  • BACK N/A
  • EPS Growth
  • SONN N/A
  • BACK N/A
  • EPS
  • SONN N/A
  • BACK N/A
  • Revenue
  • SONN $18,626.00
  • BACK $15,750.00
  • Revenue This Year
  • SONN N/A
  • BACK N/A
  • Revenue Next Year
  • SONN N/A
  • BACK N/A
  • P/E Ratio
  • SONN N/A
  • BACK N/A
  • Revenue Growth
  • SONN N/A
  • BACK N/A
  • 52 Week Low
  • SONN $1.41
  • BACK $0.98
  • 52 Week High
  • SONN $18.72
  • BACK $7.75
  • Technical
  • Relative Strength Index (RSI)
  • SONN 26.27
  • BACK 63.52
  • Support Level
  • SONN $1.41
  • BACK $1.15
  • Resistance Level
  • SONN $1.94
  • BACK $1.37
  • Average True Range (ATR)
  • SONN 0.37
  • BACK 0.12
  • MACD
  • SONN 0.05
  • BACK 0.02
  • Stochastic Oscillator
  • SONN 2.91
  • BACK 76.35

About SONN Sonnet BioTherapeutics Holdings Inc.

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.

About BACK IMAC Holdings Inc.

IMAC Holdings Inc is a provider and manager of value-based, conservative medical care combining life science advancements with traditional medical care for movement-restricting diseases and conditions in IMAC Regeneration Centers and BackSpace clinics. Its Innovative Medical Advancements and Care (IMAC) Regeneration Centers combine medical and physical procedures to improve patient experiences and outcomes and reduce healthcare costs as compared to other available treatment options.

Share on Social Networks: